Early Access Human Psca-protein (pca-hm201) - Priority Shipping [esqd4zTR]

Early Access Human Psca-protein (pca-hm201) - Priority Shipping [esqd4zTR]

The Early Access Human Psca-protein (pca-hm201) - Priority Shipping [esqd4zTR] is a premium, high-purity recombinant protein that offers exceptional research value. Derived from human cells, this protein is widely used in various scientific studies, including cancer research, immunology, and drug discovery. Its purity and reliability make it an invaluable tool for researchers seeking accurate and reproducible results.

Product Features and Specifications

The PCA-HM201 protein is produced using state-of-the-art biotechnology, ensuring a high level of purity and biological activity. Key features include:

• Purity: Over 95% pure, as assessed by SDS-PAGE.
• Specifity: Human origin, ensuring compatibility with human cell lines and biological systems.
• Concentration: Typically supplied at 1mg/ml in sterile, pH 7.4 PBS, with no added stabilizers.

These specifications make PCA-HM201 an ideal choice for a wide range of applications, including in vitro studies, protein-protein interaction assays, and as a control for immunohistochemistry.

Practical Applications and Benefits

The Early Access Human Psca-protein (pca-hm201) - Priority Shipping [esqd4zTR] is a versatile research tool that can be used in numerous scenarios, including:

• Cancer Research: PCA-HM201 can be utilized to study the role of prostate-specific antigen in tumor development and progression.
• Immunology: It serves as a valuable reagent for understanding antigen presentation and immune responses.
• Drug Discovery: PCA-HM201 can be employed to assess the efficacy of potential cancer therapeutics.

By choosing PCA-HM201, researchers gain access to a reliable and high-quality protein that can contribute significantly to their research endeavors, whether they are working in academic, pharmaceutical, or biotech settings.